HMGB1 and neoplasm: ICD is mainly characterized by calreticulin (CRT) exposure at the cell surface of dying tumor cells, the release of the ATP, HMGB1 (High-Mobility Group Box 1) and annexin A1 (ANXA1) in the extracellular space.